Treatment of indolent non-hodgkin's lymphoma with liposomal doxorubicin

被引:0
|
作者
Ponomarova, Olga V. [1 ]
Kavetsky, R. E. [1 ]
机构
[1] Ukrainian Acad Sci, Inst Expt Pathol Oncol & Radiobiol, Kiev, Ukraine
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:182 / 182
页数:1
相关论文
共 50 条
  • [21] Nonpegylated liposomal doxorubicin in the treatment of B-cell non-Hodgkin's lymphoma: where we stand
    Visani, Giuseppe
    Isidori, Alessandro
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (03) : 357 - 363
  • [22] Costs of common treatment options for indolent follicular non-Hodgkin's lymphoma
    Van Agthoven, M
    Hagenbeek, A
    Uyl-de-Groot, CA
    VALUE IN HEALTH, 2005, 8 (06) : A40 - A40
  • [23] Indolent non-Hodgkin lymphoma treatment in the new drugs era
    Miguel Juarez-Salcedo, Luis
    Dalia, Samir
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (06)
  • [24] Clinical experience with fludarabine in indolent non-Hodgkin's lymphoma
    Zinzani, PL
    HEMATOLOGY JOURNAL, 2004, 5 : S38 - S49
  • [25] Current approaches to therapy for indolent non-Hodgkin's lymphoma
    Cheson, BD
    ONCOLOGY-NEW YORK, 1998, 12 (10): : 25 - 34
  • [26] Effectiveness of radiotherapy for patients with indolent non-Hodgkin's lymphoma
    Hadi, I.
    Schummer, A.
    Eze, C.
    Dreyling, M.
    Belka, C.
    Li, M.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S487 - S488
  • [27] Lenalidomide and rituximab for untreated indolent non-Hodgkin's lymphoma
    Fowler, N. H.
    McLaughlin, P.
    Kwak, L.
    Hagemeister, F.
    Fanale, M.
    Fayad, L.
    Pro, B.
    Samaniego, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [28] Standard approaches to relapsed indolent non-Hodgkin's lymphoma
    Witzig, Thomas E.
    SEMINARS IN HEMATOLOGY, 2007, 44 (03) : S12 - S17
  • [29] Cladribine for the treatment of indolent non-Hodgkin's lymphomas
    Hoffman, MA
    SEMINARS IN HEMATOLOGY, 1996, 33 (01) : 40 - 44
  • [30] Is bortezomib an effective treatment for indolent or mantle-cell non-Hodgkin's lymphoma?
    Bertrand Coiffier
    Nature Clinical Practice Oncology, 2005, 2 : 388 - 389